Lack of a nitric-oxide response during the course of Leishmania infantum infection in the golden hamster (Mesocricetus auratus), with or without treatment with liposomal amphotericin B

Annals of Tropical Medicine and Parasitology

Volumn 92, Issue 6, 1998, Pages 685-692

  Bories, C ^a   Coffin, C ^b   Mathieu, D ^b   Bories, P N ^c   Scherman, E ^c   Rivollet, D ^b   Deniau, M ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c Hopital Albert Chenevier   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMPHOTERICIN B LIPID COMPLEX; CREATINE; CREATININE; IMMUNOGLOBULIN; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN; PROTOZOON ANTIBODY; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DRUG RESPONSE; HAMSTER; INTRACARDIAC DRUG ADMINISTRATION; LEISHMANIA INFANTUM; LIVER WEIGHT; MALE; NONHUMAN; SPLEEN WEIGHT; VISCERAL LEISHMANIASIS;

AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; BCG VACCINE; CRICETINAE; DISEASE MODELS, ANIMAL; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; MESOCRICETUS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II;

ANIMALIA; CRICETINAE; LEISHMANIA INFANTUM; MESOCRICETUS AURATUS; PROTOZOA; RODENTIA;

EID: 0032322688     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034989859140     Document Type: Article

References (29)

1. ANON. (1985). The Guiding Principles for Biomedical Research Involving Animals. Geneva: Council for International Organization of Medical Sciences.
2. ANSTEY, N. M., GRANGER, D. L. & WEINBERG, J. B. (1997). Nitrate level in malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 238.
3. BORIES, P. N. & BORIES, C. (1995). Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clinical Chemistry, 41, 904-907.
4. BORIES, C., LIANCE, M., BORIES, P. N., SENGPHOMMANACHANH, K., SIMON, F. & HOUIN, R. (1996). No evidence for increased production of nitric oxide in C57BL/6J mice infected with Echinococcus multilocularis. Annals of Tropical Medicine and Parasitolagy, 90, 641-644.
5. BORIES, C., SCHERMAN, E. & BORIES, P. N. (1997a). Serum and tissue nitrate levels in murine visceral leishmaniasis correlate with parasitic load but not host protection. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 433-436.
6. BORIES, P. N., CAMPILLO, B., AZAOU, L. & SCHERMAN, E. (1997b). Long-lasting NO overproduction in cirrhotic patient with spontaneous bacterial peritonitis. Hepatology, 25, 1328-1333.
7. BERMAN, J. D., HANSON, W, L., CHAPMAN, W. L., ALVING, C. R. & LOPEZ-BERESTEIN, G. (1986). Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrobial Agents and Chemotherapy, 30, 847-851.
8. DAVIDSON, R. N. & CROFT, S. L. (1993). Recent advances in the treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 130-131, 141.
9. DEDET, J. P. (1995). Leishmanies-leishmanioses, clinique et thérapeutique. In Encyclopédie Médico-Chirurgicale. Maladies Infectieuses, 8-506-A-20. Paris: Elsevier.
10. DÖRGER, M., JESCH, N. K., RIEDER, G., HIRVONEN, M.-J., SAVOLAINEN, K., KROMBACH, F. & MESSMER, K. (1997). Species differences in NO formation by rat and hamster alveolar macrophages in vitro. American Journal of Respiratory and Cell Molecular Biology, 16, 413-420.
11. EVANS, T. G., THAI, L., GRANGER, D. L. & HIBBS JR, J. B. (1993). Effect of in vivo inhibition of NO production in murine leishmaniasis. Journal of Immunology, 151, 907-915.
12. EVANS, T. G., THAI, L., GRANGER, D. L. & HIBBS JR, J. B. (1996). Nitric oxide production in murine leishmaniasis: correlation of progressive infection with increasing systemic synthesis of nitric oxide. American Journal of Tropical Medicine and Hygiene, 54, 486-489.
13. FAURAUT-GAMBARELLI, F., PIARROUX, R., DENIAU, M., GIUSANO, B., MARTY, P., MICHEL, G., FAUGÈRE, B. & DUMON, H. (1997). In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrobial Agents and Chemotherapy, 41, 827-830.
14. FESSI, H., STAINMESSE, S., DEVISSAGUET, J.-P. & PUISIEUX, F. (1988). French Patent 8.808.872, June 1988.
15. FUSAI, T., DENIAU, M., DURAND, R., BORIE, C., PAUL, M., RIVOLLET, D., ASTIER, A. & HOUIN, R. (1995). Action of pentamidine-bound nanoparticles against Leishmania on an in-vivo model. Parasite, 1, 319-324.
16. GARCIA, S. & BRUCKNER, D. (1993). Diagnostic Medical Parasitology, 2nd Edn. Washington, DC: American Society for Microbiology.
17. HINDLE, E. & THOMPSON, J. G. (1928). Leishmania infantum in hamsters. Proceeding of the Royal Society London, Biology, 103, 252-257.
18. LIEW, F. W., MILLOTT, S., PARKINSON, C., PALMER, R. M. J. & MONCADA, S. (1990). Macrophage killing of Leishmania parasites in vivo is mediated by nitric oxide from arginine. Journal of Immunology, 144, 4794-4797.
19. MAUËL., J., RANSIJN, A. & BUCHMULLER-ROUILLER, Y. (1991). Killing of Leishmania parasite in activated mouse macrophages is based on a L-arginine dependent mechanism that produces nitrogen derivatives. Journal of Leukocyte Biology, 49, 73-82.
20. MOZAFFARIAN, N., BERMAN, J. W. & CASADEVALL, A. (1997). Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B. Antimicrobial Agents and Chemotherapy, 41, 1731-1734.
21. OCHOA, J., UDECWU, A., BILLIAR, T., CURRAN, R., CERRA, K., SIMMONS, R. & PEITZMAN, A. (1991). Nitrogen oxide levels in patients after trauma and during sepsis. Annals of Surgery, 214, 621-626.
22. PAUL, M., DURAND, R., FESSI, H., RIVOLLET, D., HOUIN, R., ASTIER, A. & DENIAU, M. (1997). Activity of a new liposomal formulation of Amphotericin B against two strains of Leishmania infantum in a murine model. Antimicrobial Agents and Chemotherapy, 41, 1825-1829.
23. PEARSON, R. D & DE QUIEROZ SOUSA, A. (1986). Leishmaniasis and trypanosomiasis. In Experimental Models in Antimicrobial Chemotherapy, Vol. 3, eds Zak, O. & Sande, M. A. pp. 203-239. London: Academic Press.
24. REES, P. H. & KAGER, P. A. (1987). Visceral leishmaniasis and post-kala-azar dermal leishmaniasis. In The Leishmaniases in Biology and Medicine, Vol. 2, Clinical Aspects and Control, eds Peters, W. & Killick-Kendrick, R. pp. 584-615. London: Academic Press.
25. STAUBER, L. A., FRANCHINO, M & GRUN, J. (1958). An eight-day method for screening compounds against Leishmania donovani in the golden hamster. Journal of Protozoology, 5, 269-273.
26. STERNBERG, J. M. (1996). Elevated serum nitrate in Trypanosoma brucei infections: evidence for inducible nitric oxide synthesis in trypanosomiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 395.
27. STUEHR, J. D., MICHAEL, A. & MARLETTA, A. (1985). Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proceeding of the National Academy of Sciences of the United Slates of America, 82, 7738-7742.
28. TOHYAMA, M., KAWAKAMI, K. & SAITO, M. (1996). Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide. Antimicrobial Agents and Chemotherapy, 40, 1919-1923.
29. WORLD HEALTH ORGANIZATION (1996). Epidemiological Analysis of 692 Retrospective Cases of Leishmania/ IIIV Co-infection. Document WHO/LEISH/96.39. Geneva. WHO.